Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Consolidated Net Income (2016 - 2025)

PAVmed has reported Consolidated Net Income over the past 5 years, most recently at -$2.8 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income fell 341.42% year-over-year to -$2.8 million; the TTM value through Dec 2025 reached -$2.5 million, up 92.35%, while the annual FY2025 figure was -$2.5 million, 108.69% down from the prior year.
  • Consolidated Net Income for Q4 2025 was -$2.8 million at PAVmed, up from -$6.0 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $18.6 million in Q1 2025 and troughed at -$29.9 million in Q3 2022.
  • A 5-year average of -$14.4 million and a median of -$17.4 million in 2023 define the central range for Consolidated Net Income.
  • On a YoY basis, Consolidated Net Income climbed as much as 200.6% in 2025 and fell as far as 341.42% in 2025.
  • Year by year, Consolidated Net Income stood at -$19.7 million in 2021, then dropped by 24.86% to -$24.6 million in 2022, then increased by 29.16% to -$17.4 million in 2023, then skyrocketed by 106.56% to $1.1 million in 2024, then tumbled by 341.42% to -$2.8 million in 2025.
  • Business Quant data shows Consolidated Net Income for PAVM at -$2.8 million in Q4 2025, -$6.0 million in Q3 2025, and -$12.3 million in Q2 2025.